This federal contract award is a delivery order valued at $1,900.75 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award of $4,681.55 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a delivery order for the product "TYPHIM VI 25 MCG/0.5 ML VIAL 10ML" and has a firm fixed-price pricing type. The contract does not have a set-aside designation and will be performed in Conshohocken, PA, with a completion date of November 19, 2024. DMS Pharmaceutical Group Inc. is a key...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $1,040.42 contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,899.74 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a period of performance through September 27, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $20,658.62 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a period of performance through December 19, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Typhim VI 25 mcg/0.5 mL vial (10 mL) pharmaceutical supplies. The single-award Indefinite Delivery Vehicle (IDV) contract SPE2DB, valued at up to $4,999,999, was awarded by the Defense Logistics Agency (DLA) to provide a broad range of pharmaceutical items to military health facilities globally. This delivery order under the IDV has a firm fixed price of $2,080.84 and a completion...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $76,585.30 contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML 20 DOSE VIAL 10M, a specialized pharmaceutical product. The award is a delivery order under a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA. This IDC enables the...
This federal contract award is a delivery order valued at $11,263.20 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a specialized pharmaceutical product, with a completion date of December 20, 2024. The award is not associated with a set-aside designation and is a firm fixed-price delivery order. DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) on November 5, 2024. The $3,041.20 firm fixed-price delivery order (SPE2DP25F0716) is for the supply of Typhoid VI Polysaccharide (8510999864), a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (SPE2DB) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,220,848 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The $1,748.69 delivery order was issued under DMS Pharmaceutical's $4,999,999 indefinite delivery vehicle (IDV) contract SPE2DB with DLA to supply a broad range of pharmaceutical items to U.S. military medical facilities worldwide. This contract award does not...